Rapacid Mr 10mg, 20mg, 40 mg Hard gelatine capsules
PDF Leaflet Revision Date: 25 September 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of duodenal and gastric ulcers, reflux oesophagitis, and H. pylori eradication.
Dosage (summary)
Adults: 20 mg once daily; can increase to 40 mg if needed.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours
Special Populations
- Elderly
- Impaired renal function
- Impaired hepatic function
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Nelfinavir
- Atazanavir
- Clopidogrel
- Digoxin
Contraindications
- Hypersensitivity to omeprazole
- Concomitant use with nelfinavir
Common side effects
- Headache
- Abdominal pain
- Constipation
- Diarrhoea
- Nausea
Counselling Points
- Take in the morning with water
- Do not chew or crush capsules
- Report any signs of renal issues
Serious warnings
- Risk of fractures
- Hypomagnesaemia
- Acute interstitial nephritis
Important Disclaimer
The Rapacid Mr 10mg, 20mg, 40 mg Hard gelatine capsules professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
